| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/29/2009 | WO2009012953A1 Iron fortification nutritional blend |
| 01/29/2009 | WO2009012785A2 Complexes of an emulgator and a fatty acid |
| 01/29/2009 | WO2009012784A2 Methods for preparing cytotoxic complexes of emulsifier and fatty acid |
| 01/29/2009 | WO2009012600A1 Fusion proteins |
| 01/29/2009 | WO2009012571A1 Tissue kallikrein for the treatment of diseases associated with amyloid protein |
| 01/29/2009 | WO2009012569A1 TREATING OR AMELIORATING A NEUROINFLAMMATORY OR DEMYELINATING DISORDER WITH PROLACTIN AND INTERFERON-β |
| 01/29/2009 | WO2008150101A3 Chimeric polypeptide including a mussel adheisve protein and extracellular matrix |
| 01/29/2009 | WO2008146272A3 Compositions and methods for treating cxcr6/cxcl16 associated diseases |
| 01/29/2009 | WO2008145074A3 Amino acid and nucleic acid sequences and vaccine to control ectoparasite infestations in fish |
| 01/29/2009 | WO2008128064A9 Truncated analogs of peptide and polypeptide therapeutics |
| 01/29/2009 | WO2008122037A3 Inhibitors of the ceramide metabolic pathway as adjuncts to opiates |
| 01/29/2009 | WO2008120207A3 Compositions for nasal delivery |
| 01/29/2009 | WO2008114089A3 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 01/29/2009 | WO2008092015A3 Use of hsp20 peptides for treating airway smooth muscle disorders in subjects desensitized to ss -adrenergic receptor agonist therapy |
| 01/29/2009 | WO2008070049A3 Peptide and treatment for hiv-1 infection |
| 01/29/2009 | WO2007139821A3 Methods of using lrr superfamily genes and proteins |
| 01/29/2009 | WO2007133828A3 Selective vpac2 receptor peptide agonists |
| 01/29/2009 | WO2007016620A3 Methods and compositions for regenerating articular cartilage |
| 01/29/2009 | WO2006045066A9 Labeled compounds for proteasome inhibition |
| 01/29/2009 | US20090030188 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090030185 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 01/29/2009 | US20090030183 Interferon Beta-Like Molecules |
| 01/29/2009 | US20090030182 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090029938 Phosphodiesterase inhibitor for treatment and prevention of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis |
| 01/29/2009 | US20090029926 Lys-thr dipeptides and their use |
| 01/29/2009 | US20090029925 Interaction of bim with trim2, an e3 ubiquitin ligase |
| 01/29/2009 | US20090029924 Targeting Host Proteinases as a Therapeutic Strategy Against Viral and Bacterial Pathogens |
| 01/29/2009 | US20090029923 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 01/29/2009 | US20090029922 Use of S1P receptor agonists in heart diseases |
| 01/29/2009 | US20090029921 Method for Removing Endotoxin from Proteins |
| 01/29/2009 | US20090029920 Mixture with a cyclic 3', 5'-adenylic acid modulator such as forskolin, activators of adenylate cyclase or macrophages, macrophage-derived factors that stimulate cAMP, calcium ionophores, inhibitors of phosphodiesterase or beta-2-adrenoreceptor or vasoactive intestinal peptide; optional axogenic factor |
| 01/29/2009 | US20090029919 Integrins; interleukins; antifertility agents |
| 01/29/2009 | US20090029918 Method for producing mature VWF from VWF Pro-Peptide |
| 01/29/2009 | US20090029917 Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| 01/29/2009 | US20090029916 Fibroblast Growth Factor-14 |
| 01/29/2009 | US20090029915 Regulation of mineral and skeletal metabolism |
| 01/29/2009 | US20090029914 Albumin Fusion Proteins |
| 01/29/2009 | US20090029913 Novel exendin agonist compounds |
| 01/29/2009 | US20090029912 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc) |
| 01/29/2009 | US20090029911 Liquid Human Growth Hormone Formulation Containing Polyethylene Glycol |
| 01/29/2009 | US20090029910 Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes |
| 01/29/2009 | US20090029909 Modulation of synaptogenesis |
| 01/29/2009 | US20090029908 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/29/2009 | US20090029907 Recombinant Method for Production of an Erythropoiesis Stimulating Protein |
| 01/29/2009 | US20090029906 Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
| 01/29/2009 | US20090029905 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/29/2009 | US20090029904 Compositions and methods for treatment of insulin-resistance diseases |
| 01/29/2009 | US20090029903 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors |
| 01/29/2009 | US20090029902 Peptides for binding calcium carbonates and methods of use |
| 01/29/2009 | US20090029901 Process for Crystallizing Lactose Particles for Use in Pharmaceutical Formulations |
| 01/29/2009 | US20090029468 Zinc finger binding domains for cnn |
| 01/29/2009 | US20090029467 contacting targeted therapeutic with a cell deficient in a lysosomal enzyme, wherein the cell expresses the cation-independent mannose-6-phosphate receptor on the surface, thereby targeting the therapeutic enzyme to the lysosome; insulin-like growth factor 2 receptor |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090029415 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/29/2009 | US20090029404 Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in schlemm's canal cells |
| 01/29/2009 | US20090029400 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/29/2009 | US20090029380 HUMAN MutY |
| 01/29/2009 | US20090029367 Polymorphisms in pon1 are associated with elevated alanine aminotransferase levels after ximelagatran or tacrine administration |
| 01/29/2009 | US20090029361 Growth differentiation factor-7 |
| 01/29/2009 | US20090028974 Use of Botulinum Toxin Therapy for Treatment of Recalcitrant Voiding Dysfunction |
| 01/29/2009 | US20090028956 Polypeptide microparticles |
| 01/29/2009 | US20090028951 Compositions for Oral Administration of Sustained Release Glutathione, Methods for Their Production and Uses Thereof |
| 01/29/2009 | US20090028926 Method and mixture for in vivo photochemical cross-linking of collagen |
| 01/29/2009 | US20090028919 Systems and methods of promoting engraftment of a hybrid lower limb artery bypass vascular graft in a mammal |
| 01/29/2009 | US20090028916 Loaded Microspheres |
| 01/29/2009 | US20090028910 Methods for Fabrication Isolated Micro-and Nano-Structures Using Soft or Imprint Lithography |
| 01/29/2009 | US20090028908 Methods for treating neurogenic inflammation |
| 01/29/2009 | US20090028907 Botulinum toxin treatment |
| 01/29/2009 | US20090028904 Novel cochleate formulations |
| 01/29/2009 | US20090028893 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028883 Novel P-selectin Ligand Protein |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028878 Novel methods of cancer diagnosis and therapy targeted against a cancer stem line |
| 01/29/2009 | US20090028875 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 01/29/2009 | US20090028874 Synthetic Protein as Tumor-Specific Vaccine |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028866 USE OF CCR9, CCL25/TECK, AND NITEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE |
| 01/29/2009 | US20090028865 Method of treating hepatocellular carcinoma |
| 01/29/2009 | US20090028864 L-amino acid oxidase with cytotoxic activity from aplysia functata |
| 01/29/2009 | US20090028861 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 01/29/2009 | US20090028850 Prolongation of survival of an allograft by inhibiting complement activity |
| 01/29/2009 | US20090028849 Agents and methods for inhibition of airway hyperresponsiveness |
| 01/29/2009 | US20090028843 IgA allelic variants |
| 01/29/2009 | US20090028842 Dekkera/Brettanomyces Cytosine Deaminases And Their Use |
| 01/29/2009 | US20090028841 Oxygen scavenging composition, coating composition and package containing free fatty acid |
| 01/29/2009 | US20090028839 Compositions and methods for the prophylaxis and treatment of vaginal infections |
| 01/29/2009 | US20090028834 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance P or an analog thereof |
| 01/29/2009 | US20090028829 Fusion proteins for the treatment of CNS |
| 01/29/2009 | US20090028824 Systems and methods for delivering drugs |
| 01/29/2009 | US20090028823 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
| 01/29/2009 | US20090028822 Glycopegylated Interferon Alpha |
| 01/29/2009 | US20090028821 Prodrugs of cc-a1065 analogs |
| 01/29/2009 | US20090028820 Antiviral Agent |
| 01/29/2009 | US20090028819 comprising granulocyte colony stimulating factor peripheral blood stem cells (CD 34) for prevention of spontaneous abortion, preeclampsia, preterm labor or implantation failure during assisted reproduction |
| 01/29/2009 | US20090028818 Heterocyclic antiviral compounds |
| 01/29/2009 | US20090028817 Compositions and methods for soft tissue augmentation |
| 01/29/2009 | US20090028816 Treatment of depression, psychosis, and anxiety |
| 01/29/2009 | US20090028815 Diazabenzo[De]anthracen-3-one Compounds and Methods for Inhibiting Parp |
| 01/29/2009 | US20090028814 High molecular weight medicine-containing preparation in powder form for administration through mucosa |